4//SEC Filing
Sofinnova Capital VII FCPR 4
Accession 0000950103-20-016184
CIK 0001642545other
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 4:22 PM ET
Size
14.3 KB
Accession
0000950103-20-016184
Insider Transaction Report
Form 4
Sofinnova Capital VII FCPR
10% Owner
Transactions
- Sale
Common Stock
2020-08-17$55.04/sh−61,823$3,402,738→ 2,218,006 total - Sale
Common Stock
2020-08-19$57.08/sh−30,438$1,737,401→ 1,994,206 total - Sale
Common Stock
2020-08-18$55.08/sh−133,922$7,376,424→ 2,084,084 total - Sale
Common Stock
2020-08-19$55.37/sh−18,720$1,036,526→ 2,065,364 total - Sale
Common Stock
2020-08-19$56.79/sh−40,720$2,312,489→ 2,024,644 total
Footnotes (6)
- [F1]Shares held by the reporting person are also reported on Form 4 by Antoine Papiernik, one of the managing partners of Sofinnova Partners SAS, a French corporation and the management company of the reporting person. Mr. Papiernik disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest.
- [F2]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $55.00 to $55.37. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F3]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $55.00 to $55.40. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F4]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $55.00 to $55.99. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F5]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $56.00 to $56.9989. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F6]The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $57.00 to $57.49. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Documents
Issuer
Shockwave Medical, Inc.
CIK 0001642545
Entity typeother
IncorporatedFrance
Related Parties
1- filerCIK 0001616320
Filing Metadata
- Form type
- 4
- Filed
- Aug 19, 8:00 PM ET
- Accepted
- Aug 20, 4:22 PM ET
- Size
- 14.3 KB